Copper radiopharmaceuticals for theranostic applications
- 23 August 2018
- journal article
- review article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 157, 1406-1425
- https://doi.org/10.1016/j.ejmech.2018.08.051
Abstract
No abstract availableKeywords
Funding Information
- H2020-Twinning project (692146)
This publication has 172 references indexed in Scilit:
- Development of copper based drugs, radiopharmaceuticals and medical materialsBioMetals, 2012
- 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancerNuclear Medicine and Biology, 2012
- Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imagingBiomaterials, 2012
- Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click ChemistryBioconjugate Chemistry, 2011
- Evaluation of 64Cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor VasculatureMolecular Imaging & Biology, 2011
- Comparative Evaluation of Three 64Cu-Labeled E. coli Heat-Stable Enterotoxin Analogues for PET Imaging of Colorectal CancerBioconjugate Chemistry, 2010
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of FunctionalityAngewandte Chemie-International Edition, 2009
- 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activityNuclear Medicine and Biology, 2009
- Synthesis of a Cross-Bridged Cyclam Derivative for Peptide Conjugation and 64Cu RadiolabelingBioconjugate Chemistry, 2008
- Copper(ii) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysisDalton Transactions, 2007